Singapore-based Nalanda India Equity Fund just made headlines by significantly expanding its Genpact holding. According to February 18, 2026 SEC filings, the fund acquired an additional 1,015,556 shares of the IT services and business process outsourcing company, an estimated $43.92 million investment based on quarterly average pricing. What makes this move especially noteworthy is that Genpact now represents 100% of Nalanda’s reported portfolio—a concentrated bet that signals serious conviction.
The Numbers Behind Nalanda’s Strategic Move
The fund’s position in Genpact reached $641 million in value following the purchase, reflecting both the newly acquired shares and favorable price movements during the quarter. The total position value rose by $109.55 million quarter-over-quarter, representing a 6.85% change in the fund’s reportable assets under management. With 13,702,500 shares now held, Nalanda has effectively placed all its eggs in one basket—a bold move that underscores institutional confidence during a period when many investors have grown skeptical.
Genpact’s stock had declined 27.3% over the past year, significantly underperforming the S&P 500 and triggering a capitulation that may have created the buying opportunity Nalanda seized. The stock hit a 52-week low of $34.79 just days before the fund’s filing, trading at $39.18 as of mid-February 2026.
Why the Market Had Written Off Genpact Prematurely
The narrative driving Genpact’s sell-off centered on artificial intelligence rendering business process outsourcing services obsolete. Investors feared that automation would cannibalize the company’s core services, sparking a broad exit from IT and BPO stocks. Yet this concern missed a crucial reality: Genpact isn’t competing against AI—it’s leveraging it.
The company delivered 2025 revenue of $5.1 billion, marking a 7% year-over-year increase. Management has guided for another 7% revenue growth in 2026 as enterprise clients increasingly turn to Genpact for guidance on AI adoption and integration. The company’s domain expertise and existing client relationships position it as a natural advisor for organizations navigating digital transformation—a market that’s expanding, not contracting.
Valuation: The Real Story Behind Nalanda’s Confidence
Perhaps most compelling is Genpact’s current valuation. The stock now trades at a price-to-earnings ratio of 12—the lowest level in a year—despite improving growth prospects. This means Nalanda’s $43.92 million purchase came at the exact moment when the risk-reward profile shifted dramatically in the buyer’s favor.
The fund’s concentrated position suggests not just conviction, but timing. Institutional investors like Nalanda don’t typically place 100% of their portfolio in a single company on a whim. The decision to increase exposure during a market downturn, combined with improved forward guidance, indicates that sophisticated money sees a compelling entry point.
What This Transaction Signals for Broader Market Sentiment
Nalanda’s news arrives as a counterweight to the prevailing bearish consensus on IT services and outsourcing. While the Motley Fool and other commentators continue ranking Genpact below other opportunities, institutional capital is quietly flowing in. This divergence—between retail sentiment and institutional action—often precedes meaningful market repricing.
The fund’s $641 million position in Genpact is now 100% of its reported holdings, making this an all-in bet on the company’s ability to execute on AI-enabled transformation services. Whether you view this as prudent concentration or excessive risk depends on your assessment of Genpact’s competitive position and the durability of IT services demand in an AI-augmented economy.
For individual investors monitoring this situation, the key takeaway is straightforward: when institutional investors increase stakes despite negative sentiment and declining stock prices, it’s worth investigating whether the market has mispriced the opportunity.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Nalanda's Genpact News: When Institutional Investors Turn Bullish
Singapore-based Nalanda India Equity Fund just made headlines by significantly expanding its Genpact holding. According to February 18, 2026 SEC filings, the fund acquired an additional 1,015,556 shares of the IT services and business process outsourcing company, an estimated $43.92 million investment based on quarterly average pricing. What makes this move especially noteworthy is that Genpact now represents 100% of Nalanda’s reported portfolio—a concentrated bet that signals serious conviction.
The Numbers Behind Nalanda’s Strategic Move
The fund’s position in Genpact reached $641 million in value following the purchase, reflecting both the newly acquired shares and favorable price movements during the quarter. The total position value rose by $109.55 million quarter-over-quarter, representing a 6.85% change in the fund’s reportable assets under management. With 13,702,500 shares now held, Nalanda has effectively placed all its eggs in one basket—a bold move that underscores institutional confidence during a period when many investors have grown skeptical.
Genpact’s stock had declined 27.3% over the past year, significantly underperforming the S&P 500 and triggering a capitulation that may have created the buying opportunity Nalanda seized. The stock hit a 52-week low of $34.79 just days before the fund’s filing, trading at $39.18 as of mid-February 2026.
Why the Market Had Written Off Genpact Prematurely
The narrative driving Genpact’s sell-off centered on artificial intelligence rendering business process outsourcing services obsolete. Investors feared that automation would cannibalize the company’s core services, sparking a broad exit from IT and BPO stocks. Yet this concern missed a crucial reality: Genpact isn’t competing against AI—it’s leveraging it.
The company delivered 2025 revenue of $5.1 billion, marking a 7% year-over-year increase. Management has guided for another 7% revenue growth in 2026 as enterprise clients increasingly turn to Genpact for guidance on AI adoption and integration. The company’s domain expertise and existing client relationships position it as a natural advisor for organizations navigating digital transformation—a market that’s expanding, not contracting.
Valuation: The Real Story Behind Nalanda’s Confidence
Perhaps most compelling is Genpact’s current valuation. The stock now trades at a price-to-earnings ratio of 12—the lowest level in a year—despite improving growth prospects. This means Nalanda’s $43.92 million purchase came at the exact moment when the risk-reward profile shifted dramatically in the buyer’s favor.
The fund’s concentrated position suggests not just conviction, but timing. Institutional investors like Nalanda don’t typically place 100% of their portfolio in a single company on a whim. The decision to increase exposure during a market downturn, combined with improved forward guidance, indicates that sophisticated money sees a compelling entry point.
What This Transaction Signals for Broader Market Sentiment
Nalanda’s news arrives as a counterweight to the prevailing bearish consensus on IT services and outsourcing. While the Motley Fool and other commentators continue ranking Genpact below other opportunities, institutional capital is quietly flowing in. This divergence—between retail sentiment and institutional action—often precedes meaningful market repricing.
The fund’s $641 million position in Genpact is now 100% of its reported holdings, making this an all-in bet on the company’s ability to execute on AI-enabled transformation services. Whether you view this as prudent concentration or excessive risk depends on your assessment of Genpact’s competitive position and the durability of IT services demand in an AI-augmented economy.
For individual investors monitoring this situation, the key takeaway is straightforward: when institutional investors increase stakes despite negative sentiment and declining stock prices, it’s worth investigating whether the market has mispriced the opportunity.